Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...

Drugmakers have greeted 2025, implementing price hikes for 583 products within the first two days of the new year, according ...

Happy New Year, biotech friends! We’re back with news, including Merck’s decision to cut the price of its diabetes drug Januvia by 42% and Neumora’s readout on its experimental depression drug.

More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...

The FDA rejected sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control in adults with type 1 ...

Januvia, and Bridion. It also provides vaccines for various age groups under brands such as Gardasil and Pneumovax. Merck & Co., Inc. (NYSE:MRK) has recently partnered with the Chinese biopharma ...

Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...

(Journal of Clinical Endocrinology & Metabolism) At the start of the new year, Merck plans to cut the list price of its diabetes drugs sitagliptin (Januvia) and sitagliptin/metformin (Janumet ...

Alibaba to sell stake in China's hypermarket chain Sun Art. Brand prescription drugs to rise an average 4.5% in 2025. Cybertruck blast driver identified; link to New Orleans attacker growing ...